These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angelman syndrome-associated point mutations in the Zn Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870 [TBL] [Abstract][Full Text] [Related]
3. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer. Ronchi VP; Klein JM; Edwards DJ; Haas AL J Biol Chem; 2014 Jan; 289(2):1033-48. PubMed ID: 24273172 [TBL] [Abstract][Full Text] [Related]
4. An Angelman syndrome substitution in the HECT E3 ubiquitin ligase C-terminal Lobe of E6AP affects protein stability and activity. Beasley SA; Kellum CE; Orlomoski RJ; Idrizi F; Spratt DE PLoS One; 2020; 15(7):e0235925. PubMed ID: 32639967 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. Hristova VA; Beasley SA; Rylett RJ; Shaw GS J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245 [TBL] [Abstract][Full Text] [Related]
6. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity. Drews CM; Brimer N; Vande Pol SB PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989 [TBL] [Abstract][Full Text] [Related]